Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Hu Y . Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Eye; 2010 24 (8): 1414 (this issue).
Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109 (5): 920–927.
Larsson J, Zhu M, Sutter F, Gillies MC . Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 2005; 139 (5): 802–806.
Andrade RE, Muccioli C, Farah ME, Nussenblatt RB, Belfort Jr R . Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 2004; 137 (3): 572–574.
Cekiç O, Chang S, Tseng JJ, Barile GR, Del Priore LV, Weissman H et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 2005; 25 (7): 851–855.
Al-Haddad CE, Jurdi FA, Bashshur ZF . Intravitreal triamcinolone acetonide for the management of diabetic papillopathy. Am J Ophthalmol 2004; 137 (6): 1151–1153.
Park CH, Jaffe GJ, Fekrat S . Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 136 (3): 419–425.
Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004; 122 (8): 1131–1136.
Cekiç O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV et al. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Retina 2005; 25 (7): 846–850.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wu, WC., Cheng, KC. & Wu, HJ. Reply to Hu. Eye 24, 1414–1415 (2010). https://doi.org/10.1038/eye.2010.36
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2010.36